Levomilnacipran

Izvor: Wikipedija
Prijeđi na navigaciju Prijeđi na pretragu
Levomilnacipran
Klinički podaci
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 96847-55-1
ATC kod nije dodeljen
PubChem[1][2] 65833
DrugBank DB08918
Hemijski podaci
Formula ?
SMILES eMolekuli & PubHem
Farmakokinetički podaci
Poluvreme eliminacije 12 h
Izlučivanje Renalno (58%)
Farmakoinformacioni podaci
Trudnoća ?
Pravni status
Način primene Oralno

Levomilnacipran Levomilnacipran is a selective serotonin and norepinephrine reuptake inhibitor. Chemically, levomilnacipran is the 1S,2R-enantiomer of milnacipran. FDA approved on July 25, 2013.[3][4]

Reference

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.  edit
  4. David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.  edit

Literatura

[uredi | uredi kod]

Spoljašnje veze

[uredi | uredi kod]